ImmuneSpec is a next-generation immunopeptidomics platform that delivers unmatched precision in identifying peptides presented by MHC molecules. Powered by advanced mass spectrometry, ImmuneSpec provides deep, unbiased insight into immune presentation—enabling the development of safer, more effective biotherapeutics.
The platform supports early detection of immunogenic regions in biologics, reducing immune risk and guiding safer drug design. ImmuneSpec also accelerates target discovery by revealing rare neoepitopes and validates constructs by confirming that designed epitopes are effectively presented.
With rapid turnaround, high-throughput capability, and rigorous quality control, ImmuneSpec empowers researchers to advance transformative therapies—from personalized medicine to next-generation vaccines and immunotherapies.
Company Details
- Employees
- 14
- Founded
- -
- Address
- Galileilaan 18, Niel,flemish Region 2845,belgium
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.immunespec.com
- Keywords
- MHC-associated peptide proteomics, MAPPS, Immunology, Neoantigen discovery, LC-MS/MS, Peptide vaccine development, Immunopeptidomics, Ligandomics, Antigen presentation validation, Antigen discovery.
- HQ
- Niel, Flemish Region
Immunespec Questions
Immunespec's website is http://www.immunespec.com
Immunespec's LinkedIn profile is https://be.linkedin.com/company/immunespec
Immunespec has
14 employees.
View email and phone details for 14
employees at Immunespec.
Immunespec's industry is
Biotechnology Research
Immunespec's top competitors are
Etherna,
Legend Biotech,
Immunewatch,
Anicells,
Yun Probiotherapy,
Wetenschapspark Universiteit Antwerpen,
Cellcarta,
Vib,
Bionotus,
Normec Advipro.
Immunespec's categories are Biotechnology Research
Immunespec's founding year is 2023
